Login / Signup

Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review.

Hendrea Sanne Aletta TingenAlwin TubbenJ H A van 't OeverE M PastoorP P A van ZonHans L A NienhuisPeter Van der MeerRiemer H J A Slart
Published in: European journal of nuclear medicine and molecular imaging (2023)
F]FBP may not be suitable for the distinction of different types of amyloid cardiomyopathy. No studies on PET in the follow-up of ATTR amyloidosis patients were found. Future research should focus on the use of these PET tracers in the follow-up of ATTR amyloidosis patients.
Keyphrases
  • positron emission tomography
  • end stage renal disease
  • computed tomography
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • heart failure
  • prognostic factors
  • pet ct